EHang Holdings Limited (Nasdaq: EH) has partnered with the Bao'an District Government of Shenzhen municipality to advance urban air mobility (UAM) using EH216-S AAVs. The collaboration aims to develop UAM use cases, establish a demonstration center in Shenzhen's OH Bay, and offer aerial tourism services.

The Bao'an District Government will provide support for procurement, leasing, infrastructure, and operations. EHang plans to set up assembly, testing, and maintenance centers in the district.

In pre-market, $EH is currently trading at $19.25, reflecting an increase of $0.78 (4.22%).

In other news, BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), a pharmaceutical company specializing in the development and commercialization of innovative treatments for rare diseases, was upgraded by BofA Securities, shifting its rating from Neutral to Buy, along with a price target of $10.

With $BCRX closing at $7.18 on Wednesday, the price target suggests a potential upside of $2.82 or approximately 39.22%, according to the financial advisory firm's view.

The potential upside mentioned for BioCryst Pharmaceuticals is based on the assessments and views of BofA Securities, reflecting the brokerage firm's analysis and expectations for the potential growth in stock value. Investors are advised to carefully consider these opinions when making investment decisions.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)